Restoring statistical validity in group analyses of motion-corrupted MRI data.

heteroscedasticity motion artefact quality control quantitative MRI statistical image analysis

Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 04 2022
Historique:
revised: 09 12 2021
received: 06 08 2021
accepted: 14 12 2021
pubmed: 4 2 2022
medline: 28 4 2022
entrez: 3 2 2022
Statut: ppublish

Résumé

Motion during the acquisition of magnetic resonance imaging (MRI) data degrades image quality, hindering our capacity to characterise disease in patient populations. Quality control procedures allow the exclusion of the most affected images from analysis. However, the criterion for exclusion is difficult to determine objectively and exclusion can lead to a suboptimal compromise between image quality and sample size. We provide an alternative, data-driven solution that assigns weights to each image, computed from an index of image quality using restricted maximum likelihood. We illustrate this method through the analysis of quantitative MRI data. The proposed method restores the validity of statistical tests, and performs near optimally in all brain regions, despite local effects of head motion. This method is amenable to the analysis of a broad type of MRI data and can accommodate any measure of image quality.

Identifiants

pubmed: 35112434
doi: 10.1002/hbm.25767
pmc: PMC8933245
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1973-1983

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203147/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Neurobiol Aging. 2021 Jun;102:50-63
pubmed: 33765431
Magn Reson Med. 2018 Dec;80(6):2415-2426
pubmed: 29687919
PLoS One. 2012;7(3):e32379
pubmed: 22427831
Neuroimage. 2005 Sep;27(3):624-34
pubmed: 15975828
Front Neurosci. 2014 Sep 10;8:278
pubmed: 25309307
Neurology. 2011 Nov 1;77(18):1691-7
pubmed: 21975210
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Magn Reson Imaging. 2015 Jun;33(5):559-65
pubmed: 25721997
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
BMC Cardiovasc Disord. 2008 Mar 17;8:6
pubmed: 18366642
Magn Reson Med. 2002 Jun;47(6):1202-10
pubmed: 12111967
Front Neuroinform. 2016 Dec 19;10:52
pubmed: 28066227
Neuroimage. 2014 Feb 1;86:544-53
pubmed: 23921101
Radiology. 2010 Nov;257(2):455-62
pubmed: 20843991
Neuroimage. 2002 Jun;16(2):465-83
pubmed: 12030832
Hum Brain Mapp. 2016 May;37(5):1801-15
pubmed: 26876452
J Magn Reson Imaging. 2011 Jul;34(1):13-21
pubmed: 21698703
Nat Neurosci. 2016 Nov;19(11):1523-1536
pubmed: 27643430
Neuropsychopharmacology. 1998 Mar;18(3):186-96
pubmed: 9471116
Hum Brain Mapp. 2017 Jan;38(1):472-492
pubmed: 27634551
Neuroimage. 2014 Jun;93 Pt 2:176-88
pubmed: 23756203
J Psychiatry Neurosci. 2019 Jan 01;44(1):62-68
pubmed: 30565907
Neuroimage. 2018 Feb 1;166:400-424
pubmed: 29079522
BMC Psychiatry. 2009 Mar 17;9:9
pubmed: 19292899
Front Neurol. 2017 May 30;8:232
pubmed: 28611728
Hum Brain Mapp. 2018 Apr;39(4):1532-1554
pubmed: 29271053
Psychiatry Res. 2007 May 15;155(1):75-82
pubmed: 17395436
Neuroimage. 2019 Jul 1;194:191-210
pubmed: 30677501
Neuroimage. 2005 Jan 1;24(1):244-52
pubmed: 15588616
Magn Reson Med. 2008 Mar;59(3):667-72
pubmed: 18306368
Magn Reson Med. 2009 Aug;62(2):365-72
pubmed: 19526493
Front Neurosci. 2013 Jun 10;7:95
pubmed: 23772204
Neurobiol Aging. 2014 Aug;35(8):1862-72
pubmed: 24656835
Eur J Epidemiol. 2014 May;29(5):371-82
pubmed: 24840228
Neuroimage. 2015 Feb 15;107:107-115
pubmed: 25498430
J Magn Reson Imaging. 2009 Jan;29(1):198-204
pubmed: 19097114
J Am Coll Radiol. 2015 Jul;12(7):689-95
pubmed: 25963225
Neuroimage. 2018 Apr 1;169:407-418
pubmed: 29278774
PLoS One. 2017 Sep 25;12(9):e0184661
pubmed: 28945803
Hum Brain Mapp. 2016 Jul;37(7):2385-97
pubmed: 27004471
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3834-9
pubmed: 20133720
Neuroimage. 2011 Apr 15;55(4):1423-34
pubmed: 21277375
Hum Brain Mapp. 2019 May;40(7):2252-2268
pubmed: 30673158
Neuroimage. 2002 Oct;17(2):1027-30
pubmed: 12377176
Neuroimage. 2012 Mar;60(1):623-32
pubmed: 22233733
Neuroimage. 2012 Jan 2;59(1):431-8
pubmed: 21810475
Hum Brain Mapp. 2022 Apr 15;43(6):1973-1983
pubmed: 35112434
J Clin Epidemiol. 2014 Aug;67(8):850-7
pubmed: 24831050
Magn Reson Med. 2008 Dec;60(6):1396-407
pubmed: 19025906
Nat Commun. 2014 Sep 17;5:4932
pubmed: 25230200
Magn Reson Med. 2010 Jul;64(1):229-38
pubmed: 20572153
Neuroimage. 2016 Feb 15;127:11-22
pubmed: 26654788
Behav Res Methods. 2007 Nov;39(4):709-22
pubmed: 18183883
Nat Neurosci. 2016 Aug 26;19(9):1175-87
pubmed: 27571196

Auteurs

Antoine Lutti (A)

Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Nadège Corbin (N)

Centre de Résonance Magnétique des Systèmes Biologiques, UMR5536, CNRS/University Bordeaux, Bordeaux, France.
Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, UK.

John Ashburner (J)

Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, UK.

Gabriel Ziegler (G)

Institute for Cognitive Neurology and Dementia Research, University of Magdeburg, Germany.

Bogdan Draganski (B)

Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Neurology Department, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Christophe Phillips (C)

GIGA Cyclotron Research Centre - in vivo imaging, GIGA Institute, University of Liège, Liège, Belgium.

Ferath Kherif (F)

Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Martina F Callaghan (MF)

Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, UK.

Giulia Di Domenicantonio (G)

Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH